Products4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Doxorubicin Hydrochloride
Product Details
NDC Product Code
0143-9091Application Number
ANDA064097Marketing Category
ANDA (C73584)Route of Administration
INTRAVENOUSEffective Date
January 16, 2024HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
DoxorubicinActive
Code: 82F2G7BL4EClass: ACTIBQuantity: 2 mg in 1 mL
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 9 mg in 1 mL
WATERInactive
Code: 059QF0KO0RClass: IACT
Doxorubicin Hydrochloride
Product Details
NDC Product Code
0143-9090Application Number
ANDA062975Marketing Category
ANDA (C73584)Route of Administration
INTRAVENOUSEffective Date
January 16, 2024DoxorubicinActive
Code: 82F2G7BL4EClass: ACTIBQuantity: 2 mg in 1 mL
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 9 mg in 1 mL
WATERInactive
Code: 059QF0KO0RClass: IACT
Doxorubicin Hydrochloride
Product Details
NDC Product Code
0143-9089Application Number
ANDA062975Marketing Category
ANDA (C73584)Route of Administration
INTRAVENOUSEffective Date
January 16, 2024WATERInactive
Code: 059QF0KO0RClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
DoxorubicinActive
Code: 82F2G7BL4EClass: ACTIBQuantity: 2 mg in 1 mL
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 9 mg in 1 mL
Doxorubicin Hydrochloride
Product Details
NDC Product Code
0143-9088Application Number
ANDA062975Marketing Category
ANDA (C73584)Route of Administration
INTRAVENOUSEffective Date
January 16, 2024DoxorubicinActive
Code: 82F2G7BL4EClass: ACTIBQuantity: 2 mg in 1 mL
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 9 mg in 1 mL